west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "难治性癫痫" 74 results
  • 经典生酮饮食和改良阿特金斯饮食治疗儿童难治性癫痫的效果比较

    研究旨在比较改良阿特金斯饮食(Modified Atkins diet,MAD)和经典生酮饮食(Ketogenic diet,KD)在治疗儿童难治性癫痫的疗效、安全性和耐受性。研究纳入 2011 年 3 月—2014 年 3 月就诊的 1~18 岁难治性癫痫患者,将其随机分配至一种饮食治疗组(ClinicalTrials.gov,编号 NCT2100501)。痫性发作记录被用于比较饮食治疗后 3、6 个月痫性发作频率与饮食治疗前基线发作频率。研究纳入 KD 组 51 例患者,MAD 组 53 例患者。KD 组平均基线痫性发作百分比在治疗后 3 个月(KD 组 38.6%,MAD 组 47.9%)和 6 个月(KD 组 33.8%,MAD 组 44.6%)均低于 MAD 组,但差异无统计学意义[3 个月,95%CI (24.1,50.8),P=0.291;6 个月,95%CI(17.8,46.1),P=0.255]。然而,在<2 岁患儿中,KD 组痫性发作控制效果优于 MAD 组。这些患者饮食治疗开始的 3 个月内,KD 组癫痫无发作率高于 MAD 组,差异有统计学意义(KD 组 53%,MAD 组 20%,P=0.047)。MAD 组耐受性更好并且副反应更少。MAD 可能是治疗儿童难治性癫痫的首要选择,但经典 KD 更适合<2 岁患者的一线饮食治疗方案。

    Release date:2018-01-20 10:51 Export PDF Favorites Scan
  • Analysis of 24 cases of intractable temporal lobe epilepsy surgery

    ObjectiveTo investigate the status and prognosis effect of surgical operation for Temporal lobe epilepsy.MethodsRetrospective analyses were performed on 24 patients with intractable temporal lobe epilepsy who were treated by surgery in Zibo Changguo Hospital and had complete clinical and follow-up data, during the period from April 2011 to June 2014. Among them, 14 were male and 10 were female, 16 to 44 years old, the average age was (24.40±6.26) years old, and the average course of disease was (12.50±8.42) years old. The clinical characteristics and prognosis of the patients were analyzed.ResultsAll 24 patients had hippocampal sclerosis and underwent "anterior temporal lobe and medial temporal structural resection". Patients were followed up for 5~7 years, the postoperative epileptic seizure of the patient reached grade Engel Ⅰ in 20 cases (83.3%), grade Engel Ⅱ in 2 cases (8.3%) and grade Engel Ⅳ in 2 cases (8.3%).ConclusionHippocampal sclerosis and cortical dysplasia were common in 24 patients, and the operation controlling intractable epilepsy was better. In order to improve the prognosis of patients, surgical treatment should be carried out as soon as possible.

    Release date:2021-02-27 02:57 Export PDF Favorites Scan
  • The expression of EPO-R, JAK2 and STAT-5 in the human brain with refractory epilepsy

    Objective The purpose of this study was to explore the expressions of EPO-R, JAK2 and STAT-5 in the human brain with refractory epilepsy and the role in neural apotosis. Methods Collecting the brain tissue of 24 patients with intractable epilepsy (as experimental group) who were hospitalized and underwent surgery in the Epilepsy Center of the First Hospital Jilin University between March 2010 to July 2011 and 6 cases of accidental or unnatural death immediately following autopsy (as control group) as required by law during the same term. Immunohistochemical was performed to observe the expression of EPO-R, JAK2 and STAT-5 in brain tissue and statistical analysis was performed. Results ① EPO-R, JAK2 and STAT-5 were expressed in both experimental and control groups. In experimental group, the positive-cell number were 41.05±2.40, 50.21±2.50 and 60.18±2.84 under light microscope (400×). While in control group, the positive-cell number were 23.00±0.49, 27.00±0.88 and 25.93±0.33. There were significant differences between the 2 groups (P<0.001). ② There were the pathologic and ultrastructural changes in the human brain with refractory epilepsy. Under the optical microscope, we can observe that the distribution of neurons was uneven and immature neurons were visible. We can see that the nuclei were vacuolar, less cytoplasm, dark staining, hyalomitome acidophilic body, and the neurons became triangular due to degeneration. The proliferation and hyperemia appeared in small vascular and glial cells. Under the transmission electron microscope we observed degeneration and necrosis of the nerve cells, nuclear karyopyknosis, nucleolis dyssymmetry and karyolemma breakage and even dissolution. The mitochondria and astrocytes were swelling. We also saw that part of the mitochondrial cristae was abnormal. Conclusion ① We found neuronal apotosis in the human brain with refractory epilepsy. ② The expression of EPO-R, JAK2 and STAT-5 in intractable epilepsy was significantly increased in neurons and glial cells compared with the control group. The high expression of EPO-R, JAK2 and STAT-5 is unrelated with course and frequency of epileptic seizures. ③ The pathway of EPO-R/JAK2/STAT-5 may be involved in the pathophysiological processes of neural protective effect of endogenous EPO against brain injury induced by epileptic seizures.

    Release date:2018-11-21 02:23 Export PDF Favorites Scan
  • Clinical effect of cortical electrode monitoring on intractable epilepsy caused by double pathology

    ObjectiveTo investigate the clinical effect of Electro-Cortico-Graphy (ECOG) monitoring on refractory epilepsy caused by double pathology. MethodsA retrospective analysis was performed on 10 patients with refractory epilepsy who underwent surgical treatment in Hunan Brain Hospital from January 2020 to December 2021. The diagnosis of postoperative disease was dual pathology of medial temporal lobe sclerosis (MTS) and focal cortical dysplasia (FCD), and the effect of oral drugs was poor. All patients underwent full preoperative evaluation to determine the scope of excision of epileptogenic lesions. Cortical electrodes were used to monitor the location and scope of epileptic discharge during the operation. Epileptogenic lesions were excised, cortical heat cautery was performed, and then cortical EEG monitoring was performed to adjust the excision strategy. The patients were followed up for 24 to 48 months, and the prognosis was assessed according to the Engel scale. ResultsAmong the 10 patients, 1 patient had acute subdural hemorrhage after surgery, 1 patient had speech and naming disorders, but all of them were recovered at discharge. The other patients had no neurological defects such as intracranial infection, hemiplegia, aphasia, etc. Engel grade I was observed in 9 cases (90%) and Engel grade III was observed in 1 case (10%). ConclusionCortical electrode monitoring is safe and effective for refractory epilepsy caused by double pathological signs.

    Release date:2024-03-07 01:49 Export PDF Favorites Scan
  • Effect of children's medical counseling games on improving compliance with ketogenic diet and ketosis status in children with drug-refractory epilepsy

    ObjectiveTo investigate the effect of medical counseling games on ketogenic diet therapy for drug-resistant epilepsy children. MethodsA total of 98 children with drug-resistant epilepsy admitted to the neurology ward of Shenzhen Children's Hospital from January 2023 to June 2024 who were treated with ketogenic diet for the first time were selected as the study objects by random number table method, and were divided into observation group (n=49) and control group (n=49). The control group received the traditional multidisciplinary team health education mode, while the observation group received the ketogenic diet treatment based on the multidisciplinary team health education mode and participated in the customized medical counseling games intervention. The time of children reaching ketosis, the knowledge level of ketogenic diet caregivers and the retention rate of children on ketogenic diet were compared between the two groups. ResultsThe time of ketosis in observation group was earlier than that in control group (P<0.05). The knowledge level of the main caregivers of ketogenic diet and the retention rate of children with ketogenic diet at 3 months and 6 months in observation group were higher than those in control group (P<0.05). ConclusionThe use of medical counseling games in the ketogenic diet for medically refractory epilepsy is an effective therapeutic strategy that facilitates the early attainment of ketosis in children with medically refractory epilepsy, improves the knowledge of caregivers on the ketogenic diet, improves retention of children on the ketogenic diet, and serves to optimize the effectiveness of clinical outcomes, which may contribute to the quality of life of children with medically refractory epilepsy.

    Release date:2024-11-20 10:50 Export PDF Favorites Scan
  • 迷走神经刺激术治疗儿童药物难治性癫痫的研究进展

    癫痫患儿中约有 30% 为药物难治性癫痫,迷走神经刺激术(Vagus nerve stimulation,VNS)是药物难治性癫痫患儿无手术治疗指征时的一个选择。VNS 治疗癫痫的具体机制尚不明确,但长期大量的临床应用已证实其有效性和安全性,尤其是癫痫综合征,如 Lennox-Gastaut 综合征、Dravet 综合征,或难治性局灶性、多灶性癫痫均是很好的适应证。同时,临床应用 VNS 治疗难治性癫痫发现其对患儿的认知功能等方面亦有明显改善。文章从 VNS 治疗儿童药物难治性癫痫的发展史、参数设置、适应证、可能机制、临床应用,以及局限性和未来发展等方面进行综述,以期为相关临床应用提供一定参考。

    Release date:2020-01-09 08:49 Export PDF Favorites Scan
  • Surgical analysis of patients with GATOR1 complex gene mutations presenting mainly with epilepsy

    Background To summarize the genetic characteristics of GATOR1 complex gene mutations and the surgical prognosis of patients with refractory epilepsy. Methods A retrospective analysis was conducted on 16 patients with GATOR1 complex gene mutations who presented with mainly refractory epilepsy and underwent surgical treatment at the Epilepsy Center of Tsinghua University Yuquan Hospital from May 2019 to August 2024. The follow-up period ranged from 0.5 to 4.0 years. The genetic characteristics, clinical data, treatment, and prognosis of the patients were analyzed. Results Among the 16 patients, 9 were male and 7 were female, with an onset age ranging from 0.6 to 9.4 years, and seizure frequency ranging from once a day to dozens of times a day. Twelve patients (75.0%) had no seizures after surgery, and three of them had completely stopped taking medication. EEG were focal or multifocal, and all clinical seizures were monitored. Two patients had negative MRI. Among the 16 patients, there were 8 with DEPDC5 gene mutations, 5 with NPRL3 gene mutations, and 3 with NPRL2 gene mutations. Conclusions Patients with refractory epilepsy related to GATOR1 complex gene mutations are good surgical candidates, with a high rate of no seizures after surgery. For confirmed patients, surgical treatment should be considered.

    Release date: Export PDF Favorites Scan
  • PET-CT 和 PET-MRI 在药物难治性癫痫中的研究进展

    手术是药物难治性癫痫的主要治疗手段,手术成功的关键在于术前对致痫灶的精确定位。近年来神经影像技术迅速发展,在难治性癫痫患者术前评估及疗效评价中发挥着重要的作用。本文对 PET-CT 和 PET-MRI 在药物难治性癫痫患者术前评估、预后判断以及 PET 脑受体显像剂等方面作一综述。

    Release date:2021-06-24 01:24 Export PDF Favorites Scan
  • 大麻二酚在儿童和成人耐药性癫痫的长期安全性和治疗效果评价:基于扩大受试试验的结果

    自 2014 年以来,该研究小组进行了一项扩大受试研究(Expanded‐access program,EAP),对难治性癫痫(Treatment‐resistant epilepsies,TRE)患者添加使用了大麻二酚(Cannabidiol,CBD)药物。报告截至 2016 年 12 月关于 CBD 的安全性和有效性的中期结果。研究纳入了 25 个位于美国的医学中心,这些中心招募了服用稳定剂量抗癫痫药物(AEDs)的难治性癫痫患者。在 4 周的基线期内,患者 1 监护人记录所有可计数的癫痫发作类型和次数。患者口服 CBD 的起始剂量为 2~10 mg /(kg·d),最大剂量定为 25~50 mg /(kg·d)。在初始的 16 周内每 2~4 周对患者进行一次访视,此后每 2~12 周进行一次访视。研究数据包括每月惊厥性癫痫和总癫痫发作频率与基线相比的百分比变化,以及与基线相比癫痫发作减少≥50%、≥75% 和 100% 的患者百分比。最后对数据进行描述性分析,使用末次观测值结转法(LOCF 法)来分析丢失的数据。每次访视均记录不良事件(Adverse events,AEs)。安全性分析囊括了 607 例患者,其中有 146 例(24%)退出;最常见的原因是缺乏疗效[89(15%)]和 AEs[32(5%)]。患者的平均年龄为 13 岁(范围为 0.4~62)。联用 AEDs 的数量为 3 种(范围为 0~10)。CBD 的中位剂量为 25 mg /(kg·d);中位治疗时间为 48 周。联用 CBD 后,在第 12 周时,每月惊厥发作的中位数减少了 51%,总癫痫发作减少了 48%,结果与随访 96 周后的发作次数相似。在第 12 周,惊厥性癫痫发作减少百分比≥50%、≥75% 和 100% 患者比例分别为 52%、31% 和 11%,此结果与 96 周时相似。CBD 的耐受性一般;最常见的 AEs 为腹泻(29%)和嗜睡(22%)。

    Release date:2020-01-09 08:49 Export PDF Favorites Scan
  • 深部脑刺激治疗药物难治性癫痫的研究现状

    癫痫是一种短暂性脑神经异常放电引起人体机能出现异常的一种疾病,该疾病目前已然波及全球5 000万余人,人们通常使用药物控制发作,尽管引入了各种新型抗癫痫发作药物(Anti-seizure medications,ASMs),仍有约1/3的患者无法通过ASMs正规治疗得到有效控制,进而发展为药物难治性癫痫(Drug-resistant epilepsy,DRE),持续的癫痫发作会对患者的身体、心理、家庭以及社会造成严重的负担。随着神经外科对立体定向技术的逐步深入研究,研究发现深部脑刺激(Deep brain stimulation,DBS)是一种广泛应用于精神和神经疾病的有效治疗手段,目前,DBS在治疗帕金森病(Parkinson’s disease,PD)方面已取得良好成效,同时该技术的可调节性、可逆性及良好的安全性促使人们通过DBS对精神神经系统疾病进行更深入的研究。目前世界各地已有一定数量的患有不同精神障碍或神经障碍的患者接受DBS治疗,其运用于DRE也得到了良好疗效,本文就DBS的神经调控机制、相关靶点、副作用及研究现状作如下概述,以期对DRE的治疗提供治疗新思路。

    Release date:2023-03-13 02:15 Export PDF Favorites Scan
8 pages Previous 1 2 3 ... 8 Next

Format

Content